# Novartis AG: financial statements, quarterly

NVS · NYSE · CIK 1114448 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nvs.md) · [Financials](/companies/nvs/financials.md) · [Filings](/companies/nvs/filings.md) · [Insiders](/companies/nvs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nvs/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2015-12-31) | period not labelled (2016-12-31) | period not labelled (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [4.7](/filings/0001370368-19-000002.md) | [7.0](/filings/0001370368-20-000003.md) | [8.9](/filings/0001370368-21-000006.md) | [13.3](/filings/0001370368-22-000010.md) | [11.1](/filings/0001370368-23-000048.md) | [9.7](/filings/0001370368-24-000004.md) | [12.4](/filings/0001370368-25-000004.md) | [7.5](/filings/0001114448-26-000004.md) | [13.4](/filings/0001114448-26-000004.md) | [11.5](/filings/0001114448-26-000004.md) | [11.4](/filings/0001114448-26-000004.md) |
| Current assets | $bn | not reported | not reported | [28.2](/filings/0001370368-19-000002.md) | [35.6](/filings/0001370368-20-000003.md) | [29.5](/filings/0001370368-21-000006.md) | [29.7](/filings/0001370368-22-000010.md) | [45.7](/filings/0001370368-23-000048.md) | [36.9](/filings/0001370368-24-000004.md) | [30.5](/filings/0001370368-25-000004.md) | [29.7](/filings/0001114448-26-000004.md) | [30.5](/filings/0001114448-26-000004.md) |
| Total assets | $bn | not reported | not reported | [133](/filings/0001370368-19-000002.md) | [146](/filings/0001370368-20-000003.md) | [118](/filings/0001370368-21-000006.md) | [128](/filings/0001370368-22-000010.md) | [132](/filings/0001370368-23-000048.md) | [117](/filings/0001370368-24-000004.md) | [99.9](/filings/0001370368-25-000004.md) | [102](/filings/0001114448-26-000004.md) | [111](/filings/0001114448-26-000004.md) |
| Current liabilities | $bn | not reported | not reported | [23.4](/filings/0001370368-19-000002.md) | [29.6](/filings/0001370368-20-000003.md) | [28.3](/filings/0001370368-21-000006.md) | [33.1](/filings/0001370368-22-000010.md) | [30.2](/filings/0001370368-23-000048.md) | [28.7](/filings/0001370368-24-000004.md) | [26.4](/filings/0001370368-25-000004.md) | [28.7](/filings/0001114448-26-000004.md) | [27.3](/filings/0001114448-26-000004.md) |
| Total liabilities | $bn | not reported | not reported | [58.9](/filings/0001370368-19-000002.md) | [66.9](/filings/0001370368-20-000003.md) | [62.8](/filings/0001370368-21-000006.md) | [71.1](/filings/0001370368-22-000010.md) | [64.0](/filings/0001370368-23-000048.md) | [58.0](/filings/0001370368-24-000004.md) | [53.2](/filings/0001370368-25-000004.md) | [58.1](/filings/0001114448-26-000004.md) | [64.4](/filings/0001114448-26-000004.md) |
| Shareholders' equity | $bn | [77.1](/filings/0001370368-19-000002.md) | [74.9](/filings/0001370368-20-000003.md) | [74.2](/filings/0001370368-19-000002.md) | [78.6](/filings/0001370368-20-000003.md) | [55.5](/filings/0001370368-21-000006.md) | [56.6](/filings/0001370368-22-000010.md) | [67.7](/filings/0001370368-23-000048.md) | [59.3](/filings/0001370368-24-000004.md) | [46.7](/filings/0001370368-25-000004.md) | [44.0](/filings/0001114448-26-000004.md) | [46.1](/filings/0001114448-26-000004.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 1,908,151,679 at 2025-12-31, from the cover of the [20-F filed 2026-02-04](/filings/0001114448-26-000004.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.